Results 71 to 80 of about 9,935 (174)

Prospective pilot study utilizing changes in quantitative values obtained on serial fluorine‐18 fluorodeoxyglucose (18F‐FDG) positron emission tomography–computed tomography (PET/CT) in dogs with appendicular osteosarcoma before and after stereotactic body radiation therapy (SBRT) and carboplatin chemotherapy to assess for prediction of survival and therapeutic effectiveness

Veterinary Radiology &Ultrasound, Volume 65, Issue 4, Page 408-416, July 2024.
Abstract Serial fluorine 18 fluorodeoxyglucose (18F‐FDG) positron emission tomography–CT (PET/CT) is commonly used in human oncology to prognosticate and evaluate for therapeutic effectiveness. In this pilot study, dogs with naturally occurring appendicular osteosarcoma were evaluated with serial 18F‐FDG PET/CT in an attempt to assess for response to ...
Tiffany W. Martin, Lynn Griffin
wiley   +1 more source

Transient 18F-Fluorodeoxyglucose Activity on PET/CT of Herniation Pit in Thyroid Cancer Patient: A Case Report

대한영상의학회지, 2017
A herniation pit is a benign bone pit characterized by its femoral location and surrounding sclerotic margin. Few reports have been issued on the fluorodeoxyglucose (FDG) positron emission tomography findings of herniation pit.
Yun Hee Kang, Geon Park
doaj   +1 more source

Diagnostic Role of F-18 Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography in Restaging of Upper Urinary Tract Urothelial Carcinoma

Journal of Urological Surgery, 2017
Objective: To retrospectively evaluate contribution of F-18 fluorodeoxyglucose positron-emission tomography/computed tomography (18FDG-PET/CT) to re-staging of upper urinary tract urothelial carcinoma (UTUC). Materials and Methods: This study included a
Hakan Öztürk
doaj   +1 more source

Novel genetic assessments for cancer patients: where does medical imaging stand in the future of personalised medicine?

Journal of Medical Radiation Sciences, Volume 71, Issue 1, Page 7-9, March 2024.
As our understanding of genetics in cancer care improves, the role of personalised medicine for patients continues to grow. With the increasing emergence of novel technologies for patient assessment, such as the evaluation of circulating tumour DNA, we must reflect on the potentially changing role that medical imaging will play in the future of optimal
Sally L. Ayesa
wiley   +1 more source

The prognostic value of F18 Fluorothymidine positron emission tomography for assessing the response of malignant pleural mesothelioma to chemotherapy – A prospective cohort study

Journal of Medical Imaging and Radiation Oncology, Volume 68, Issue 1, Page 57-66, February 2024.
Abstract Introduction Malignant pleural mesothelioma is difficult to prognosticate. F18‐Fluorodeoxyglucose positron emission tomography (FDG PET) shows promise for response assessment but is confounded by talc pleurodesis. F18‐Fluorothymidine (FLT) PET is an alternative tracer specific for proliferation.
Isaac J May, Anna K Nowak, Roslyn J Francis, Martin A Ebert, Satvinder S Dhaliwal   +4 more
wiley   +1 more source

Development of antibody‐drug conjugates in cancer: Overview and prospects

Cancer Communications, Volume 44, Issue 1, Page 3-22, January 2024.
Abstract In recent years, remarkable breakthroughs have been reported on antibody‐drug conjugates (ADCs), with 15 ADCs successfully entering the market over the past decade. This substantial development has positioned ADCs as one of the fastest‐growing domains in the realm of anticancer drugs, demonstrating their efficacy in treating a wide array of ...
Dan‐Yun Ruan, Hao‐Xiang Wu, Qi Meng, Rui‐Hua Xu   +3 more
wiley   +1 more source

Paraneoplastic ocular sarcoidosis in the setting of recurrent rectal carcinoid tumor diagnosed by F18-fluorodeoxyglucose PET CT

American Journal of Ophthalmology Case Reports, 2020
Nuclear medicine imaging can provide a noninvasive means of distinguishing inflammatory mass lesions from oncologic intraocular tumors.We report a case of paraneoplastic ocular sarcoidosis with choroidal mass lesions that was initially concerning for choroidal metastasis of a primary carcinoid tumor.
Elizabeth D. Marlow, Lisa J. Faia, Dafang Wu, Nathan Farley, Sandeep Randhawa   +4 more
openaire   +3 more sources

F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in a Rare Case of Recurrent Malignant Mixed Mullerian Tumor

World Journal of Nuclear Medicine, 2014
We report a case of 66-year-old female with previous history of histopathologically proven. Malignant mixed mullerain tumor of the uterus in whom positron emission tomography/computed tomography (CT) done for characterization of soft tissue lesion in ...
Amit Bhoil, Raghava Kashyap, Anish Bhattacharya, Bhagwant Mittal   +3 more
doaj   +1 more source

Myocardial-to-background ratio in F18-fluorodeoxyglucose PET in cardiac sarcoidosis for diagnosis and evaluation of therapeutic response

IJC Heart & Vasculature
18F-fluorodeoxyglucose positron emission tomography (FDG-PET) is recommended for diagnosis and evaluation of therapy in patients with cardiac sarcoidosis (CS).FDG uptake parameters were investigated semi-quantitatively in biopsy-proven CS at time of diagnosis (CSD) and during immunosuppressive therapy (CST) and in controls.We studied 11 patients with ...
Laura Ueberham, Theresa Kluge, Konrad Latuscynski, Hans Ebbinghaus, Joanna Jozwiak-Nozdrzykowska, Stephan Renziehausen, Annika Reuser, Kerstin Bode, Regine Kluge, Ulrich Laufs, Osama Sabri, Borislav Dinov   +11 more
openaire   +3 more sources

Multilocular Thymic Cyst with High F¹⁸ Fluorodeoxyglucose Uptake and Rheumatoid Arthritis: A Case Report. [PDF]

J Clin Med
Background: multilocular thymic cysts are uncommon acquired cysts in the anterior mediastinum caused by incomplete thymic involution. They may be associated with autoimmune diseases, such as rheumatoid arthritis and systemic sclerosis. Methods: a 61-year-old man with a history of rheumatoid arthritis for 8 years was referred to our unit because of a ...
Ferrante F, Poggi C, Centofanti A, Vaz Sousa R, Sebastianelli V, Evangelista AP, Mattoccia F, Zacchini B, De Giacomo T, Anile M, Venuta F, Bassi M.   +11 more
europepmc   +3 more sources